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Background: Body mass index (BMI) and waist circumference (WC) are the most used anthropometric measures to
identify obesity. While BMI is considered to be a simple and accurate estimate of general adiposity, WC is an
alternative surrogate measure of visceral obesity. However, WC is subject to significant inter-examiner variation. The
aim of the present study was to correlate BMI and WC measures in a group of Brazilian adults to determine the
most accurate BMI values for predicting abnormal WC.
Methods: BMI and WC were measured in 1184 volunteers (45.6 ± 17.3 yrs; 69% female) using standard procedures.
Abnormal WC was defined as ≥88 cm in women and ≥102 cm in men using the traditional criteria, and ≥80 cm in
women and ≥90 cm in men using the new criteria. Statistical analysis involved the calculation of Pearson’s
correlation coefficients and receiver operating characteristic (ROC) curves.
Results: BMI was strongly correlated with WC (women: r = 0.87, p < 0.0001, area under ROC curve = 0.93 ± 0.1; men:
r = 0.89, p < 0.0001, area under ROC curve = 0.94 ± 0.01). The most accurate BMI cutoff point for abnormal WC was
27.1 kg/m2 for men and 26.8 kg/m2 for women using the traditional WC criteria, and 24.7 kg/m2 for men and
24.9 kg/m2 for women using the new WC criteria.
Conclusion: Based on the strong correlation found with WC, BMI can be used as the primary anthropometric
measure to estimate adiposity, since both obese and most overweight subjects will have abnormal WC.
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Obesity is the fastest-growing chronic disease in both chil-
dren and adults, and is becoming a global epidemic. In
2008, an estimated 1.5 billion adults worldwide were con-
sidered to be overweight or obese [1]. This public health
concern is the cause of a number of comorbidities, being
associated with high health care costs. Obesity is a risk fac-
tor for a variety of diseases, such as type 2 diabetes melli-
tus, cardiovascular disease, hypertension and cancer [2-4].
Overweight in adults is defined as a body mass index
(BMI = weight in kilograms/height in meters squared) of
25.0 to 29.9 kg/m2, while obesity is defined as a BMI ≥* Correspondence: marciowlauria@gmail.com
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reproduction in any medium, provided the or30.0 kg/m2 [5]. BMI was first described by Adolphus
Quetelet in the mid- nineteenth century, based on the
observation that body weight is proportional to height
squared in adults with normal body frames [6]. BMI is
widely employed as an anthropometric estimate of gen-
eral adiposity.
In recognition that visceral fat accumulation increases
the risk of metabolic disease, waist circumference (WC)
has been used as an alternative surrogate measure of
obesity. Abnormal WC is traditionally defined as
≥88 cm in women and ≥102 cm in men, based on cutoff
points advocated by Lean et al. in 1995 [7]. Recently,
however, new cutoff points have been proposed for ab-
normal WC taking into consideration ethnic aspects. In
South Americans, abnormal WC is defined as ≥80 cm in
women and ≥90 cm in men. These values are based ontd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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national Diabetes Federation (IDF) [8].
However, while weight and height measurements are
relatively simple and accurate, WC is subject to signifi-
cant inter-examiner variation, which leads to concerns
regarding its reliability. Furthermore, BMI has been de-
scribed as a better predictor of cardiovascular events
than WC in some studies [9-11].
The aim of the present study was to correlate BMI
and WC in a group of Brazilian adults to determine the
most accurate BMI values that best predict abnormal
WC in men and women.
Methods
A total of 1184 subjects were consecutively evaluated
and included in the present study. The volunteers spon-
taneously presented for a medical appointment at a gen-
eral endocrine clinic at the Felício Rocho Hospital,
Brazil, between March 2011 and February 2012. The ex-
clusion criteria were the following: age < 18 yrs, history
of abdominoplasty, history of solid organ transplant and
chronic kidney disease.
All the data were evaluated by physicians trained in
measuring weight, height and WC using standard tech-
niques. BMI was obtained from height and weight mea-
surements with the subjects barefoot and wearing light
clothing. A scale with accurate weighing up to 150 kg
was used for weight determination. Height was mea-
sured to the nearest 1 cm using a stadiometer. For this
measurement, the participants were positioned with
heels, buttocks, shoulder blades and back of the head in
contact with the backboard of the stadiometer and the
top of the head in the Frankfort horizontal plane. BMI
was calculated as weight in kilograms divided by height
in meters squared (kg/m2).
WC was measured with the subject in the standing
position, at the end of exhalation, using a non-elastic
measuring tape placed horizontally at the midpoint be-
tween the lowest rib and top of the iliac crest, as defined
by the World Health Organization. Two different cutoff
points were used for establishing abnormal WC: 1)
≥88 cm in women and ≥102 cm in men (traditional cri-
teria); and 2) ≥ 80 cm in women and ≥90 cm in men
(new criteria). The subjects were allocated into two
groups (normal and abnormal) based on these two cutoff
points.
To estimate the most accurate BMI cutoff point for
discriminating normal from abnormal WC, receiving op-
erating characteristic (ROC) curves were constructed
and separated by gender using both WC classification
criteria. The point closest to the maximum sensitivity
and specificity point was selected as the cutoff.
Correlation analyses were performed between the BMI
and WC using Pearson’s correlation coefficient (r) andarea under ROC curves with 95% confidence interval
{AUC (95% CI)}. An r value >0.7 indicated a strong correl-
ation; r = 0.4 to 0.7 indicated a moderate correlation, and
r <0.4 denoted a weak correlation. The Prism 4.0 software
(Graph Pad, San Diego, CA, USA) was used for all analyses
and a p value <0.05 was deemed statistically significant.
Results and discussion
Mean patient age was 45.6 ± 17.3 yrs. Women accounted
for 69% of the sample. Mean BMI was 25.4 ± 4.8 kg/m2
for men and 27.1 ± 5.9 kg/m2 for women. Mean WC was
89.9 ± 14.4 cm for men and 88.9 ± 15.1 cm for women.
Pearson’s correlation coefficient between BMI and WC
was 0.89 for men (p < 0.0001) and 0.87 for women (p <
0.0001). The AUC (95% CI) between BMI and WC using
the traditional classification was 0.94 (0.91-0.96) for men
and 0.93 (0.91-0.95) for women (Figure 1). The AUC
(95% CI) between BMI and WC using the new criteria
was 0.95 (0.92-0.97) for men and 0.93 (0.91-0.94) for
women (Figure 2).
The most accurate BMI cutoff point for abnormal WC
was 27.1 kg/m2 for men (sensitivity: 96%; specificity:
81%) and 26.8 kg/m2 for women (sensitivity: 82%; speci-
ficity: 89%) using the traditional classification (Figure 1).
Using the new criteria, the most accurate BMI cutoff
point for abnormal WC was 24.7 kg/m2 for men (sensi-
tivity: 92%; specificity: 84%) and 24.9 kg/m2 for women
(sensitivity: 82%; specificity: 91%) (Figure 2).
The present cross-sectional study with >1000 subjects
demonstrated a strong correlation between BMI and
WC in both genders. This study involved patients at
ages ranging from 18 to 90 yrs. Moreover, no distinc-
tions were made regarding ethnicity. In fact, considering
the ethnic mix of the Brazilian population, the present
findings may also apply to other populations. Strong cor-
relation between BMI and WC (80-85%) has also been
described in large cohorts [9,10]. Therefore, BMI pro-
vides a good estimation of WC in the majority of pa-
tients and can reasonably replace it, which is a very
convenient feature in clinical practice.
BMI is the most widely employed anthropometric
measure, due in part to its convenience, safety and min-
imal cost. Several studies have related BMI to mortality
and morbidity rates, thereby demonstrating that subjects
with normal BMI or slightly overweight are in the lower
risk group [12]. A recent meta-analysis found that obes-
ity class 2 and 3 (BMI = 35–39.9 and ≥ 40 kg/m2, re-
spectively) were significantly associated with increased
overall mortality, while class 1 obesity (BMI = 30–
34.9 kg/m2) was not associated with higher mortality
rates and overweight was actually associated with signifi-
cantly lower overall mortality rates [13].
On the other hand, using BMI alone for obesity assess-
ment could be a limitation because it reflects both fat
Figure 1 ROC curve for prediction of central obesity (WC = 102 cm in men and 88 cm in women). (A) for men: cut-off value = 27.1 kg/m2
{sensitivity: 96%; specificity: 81%, AUC (95% CI) = 0.94 (0.91-0.96)} (B) for women: cut-off value = 26.8 kg/m2 {sensitivity: 82%; specificity: 89%, AUC
(95% CI) = 0.93 (0.91-0.95)} AUC (95% CI) = area under ROC curves with 95% confidence interval; BMI-F = Body mass index in men, BMI-M = Body
mass index in men.
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[14]. Okorududu et al. conducted a systematic review of
studies evaluating the performance of BMI in the detec-
tion of body adiposity and found that cutoff points for
the diagnosis of obesity have high specificity but low sensi-
tivity regarding the identification of adiposity, as half of the
individuals with a high percentage of fat were not identified
using this measure [15]. Moreover, BMI is particularly in-
accurate in subjects with elevated lean body mass, such as
athletes, and cannot be generalized among different ethnic
groups. This measure is also criticized because it makes no
difference between men and women [16].Figure 2 ROC curve for prediction of central obesity (WC = 90 cm in m
for men {sensitivity: 92%; specificity: 84%, AUC (95% CI) = 0.95 (0.92-0.97)}. (
specificity: 91%, AUC (95% CI) = 0.93 (0.91-0.94)}. AUC (95% CI) = area under
men, BMI-M = Body mass index in men.WC, in turn, provides an estimation of abdominal fat
and has been related to insulin resistance and cardiovas-
cular risk. It is the cornerstone of the IDF definition of
metabolic syndrome [8]. However, WC measurement is
frequently unreliable, since it varies depending on the
precise site at which the measurement is performed
[17,18]. A study published in 2008 determined excellent
inter-observer reliability for weight, height and derived
BMI (r >0.99), but unsatisfactory reliability for WC
(r =0.92). Only 1% of volunteers were misclassified as
overweight or obese based on the BMI, whereas the use
of WC led to misclassification in 6% of cases [19].en and 80 cm in women). (A) for men: cut-off value = 24.7 kg/m2
B) for women: cut-off value = 24.9 kg/m2 for women {sensitivity: 82%;
ROC curves with 95% confidence interval; BMI-F = Body mass index in
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mortality or cardiovascular disease, according to recent
data from large cohorts [9-11]. These results challenge
current recommendations on obesity-related cardiovas-
cular risk management based on WC and underscore
the need for further research to improve the reliability of
anthropometric measurements by physicians.
In 2006, IDF recommended modifications in the defin-
ition of abnormal WC, taking into account ethnic as-
pects [8]. In the present study, the impact of these
modifications in the relation between WC and BMI was
demonstrated. Using the traditional criteria, BMI above
27 kg/m2 was the most accurate cutoff point for the pre-
diction of abnormal WC in both genders. Interestingly,
the use of the new and more stringent criteria deter-
mined that all overweight/obese subjects had abnormal
WC and the most accurate cutoff point was approxi-
mately 25 kg/m2 in both men and women. This repre-
sents a controversial issue since overweight has been
associated with significantly lower mortality overall rela-
tive to the normal weight category [13].
Conclusions
Based on the present findings of strong correlation with
WC, BMI can reasonably be used as the first anthropo-
metric measure to estimate adiposity since obese and
the majority overweight subjects will have abnormal
WC. For these patients, WC measure can be waived. For
patients with a lower BMI, WC remains informative and
has yet to be determined.
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